We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGY icon
1251
Vaalco Energy
EGY
$540M
$2.8M 0.01%
618,949
-170,797
-22% -$781K
RENEW
1252
CALL
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$2.8M 0.01%
266,663
IVCA
1253
DELISTED
Investcorp India Acquisition Corp
IVCA
$2.79M 0.01%
265,860
-434,138
-62% -$4.53M
ZEOWW
1254
CALL
Zeo Energy Corp Warrants
ZEOWW
$2.79M 0.01%
259,668
OGN icon
1255
Organon & Co
OGN
$3.55B
$2.78M 0.01%
+118,405
New +$3.18M
WRAC.WS
1256
CALL
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$2.77M 0.01%
269,768
NHC icon
1257
National Healthcare
NHC
$3.61B
$2.76M 0.01%
+47,545
New +$2.73M
LNN icon
1258
Lindsay Corp
LNN
$1.17B
$2.75M 0.01%
18,202
-807
-4% -$122K
HLMN icon
1259
Hillman Solutions
HLMN
$1.6B
$2.75M 0.01%
326,682
-330,617
-50% -$2.88M
PNFP icon
1260
Pinnacle Financial Partners Inc
PNFP
$15.9B
$2.74M 0.01%
+49,700
New +$3.49M
CRNC icon
1261
Cerence
CRNC
$368M
$2.73M 0.01%
97,118
-340,914
-78% -$8.75M
SOVO
1262
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$2.73M 0.01%
+163,410
New +$2.3M
CABA icon
1263
Cabaletta Bio
CABA
$445M
$2.72M 0.01%
329,292
+277,321
+534% +$2.6M
AEHR icon
1264
Aehr Test Systems
AEHR
$2.27B
$2.72M 0.01%
87,601
+55,110
+170% +$1.78M
MET icon
1265
PUT
MetLife
MET
$62.7B
$2.71M 0.01%
46,800
+32,200
+221% +$2.17M
PSPC.WS
1266
CALL
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$2.7M 0.01%
266,663
APPF icon
1267
AppFolio
APPF
$6.31B
$2.68M 0.01%
21,538
+17,196
+396% +$2.07M
SCS
1268
DELISTED
Steelcase
SCS
$2.68M 0.01%
+317,758
New +$2.44M
KBWB icon
1269
Invesco KBW Bank ETF
KBWB
$6.9B
$2.67M 0.01%
63,600
-78,330
-55% -$4.1M
STX icon
1270
Seagate
STX
$169B
$2.67M 0.01%
+40,349
New +$2.57M
SOL
1271
DELISTED
Emeren Group
SOL
$2.66M 0.01%
597,990
+106,596
+22% +$501K
UNP icon
1272
Union Pacific
UNP
$175B
$2.65M 0.01%
13,178
-744,317
-98% -$151M
CORT icon
1273
Corcept Therapeutics
CORT
$10.1B
$2.65M 0.01%
+122,126
New +$2.68M
JGGC
1274
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$2.64M 0.01%
254,318
VHAQ.WS
1275
CALL
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$2.64M 0.01%
239,823

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.